(Z)-2-Hydrazono-4-methyl-6-(1H-pyrazol-1-yl)-1,2-dihydropyrimidine

Catalog No. :
ACLFKS112
CAS No. :
1537190-57-0
Molecular Formula :
C8H10N6
Molecular Weight :
190.21

IUPAC Name:2-hydrazineyl-4-methyl-6-(1H-pyrazol-1-yl)pyrimidine

(Z)-2-Hydrazono-4-methyl-6-(1H-pyrazol-1-yl)-1,2-dihydropyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$253.00Login to see priceInquiryInquiry
1g97%$747.00Login to see priceInquiryInquiry
5g97%$2483.00Login to see priceInquiryInquiry
10g97%$3483.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-2-Hydrazono-4-methyl-6-(1H-pyrazol-1-yl)-1,2-dihydropyrimidine
IUPAC Name2-hydrazineyl-4-methyl-6-(1H-pyrazol-1-yl)pyrimidine
MDL No.MFCD24003045
Molecular FormulaC8H10N6
Molecular Weight190.21
SMILESCC(C=C(N/1)N2N=CC=C2)=NC1=N/N
InChI KeyKSHFMTODZRMFLF-UHFFFAOYSA-N
Synonym2-hydrazinyl-4-methyl-6-(1H-pyrazol-1-yl)pyrimidine;Pyrimidine, 2-hydrazinyl-4-methyl-6-(1H-pyrazol-1-yl)-
CAS No.1537190-57-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLFKS112 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLFKS112 route product structure diagram
    ACLFKS1121537190-57-0
Inquiry

2. ACLFKS112 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLFKS112 route product structure diagram
    ACLFKS1121537190-57-0
Inquiry

Comments (0)